These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34740867)

  • 21. [Mild cognitive impairment in Parkinson's disease].
    Wada K; Nakashima K
    Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia].
    Toribio-Diaz ME; Carod-Artal FJ
    Rev Neurol; 2015 Jul; 61(1):14-24. PubMed ID: 26108904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.
    Hoogland J; van Wanrooij LL; Boel JA; Goldman JG; Stebbins GT; Dalrymple-Alford JC; Marras C; Adler CH; Junque C; Pedersen KF; Mollenhauer B; Zabetian CP; Eslinger PJ; Lewis SJG; Wu RM; Klein M; Rodriguez-Oroz MC; Cammisuli DM; Barone P; Biundo R; de Bie RMA; Schmand BA; Tröster AI; Burn DJ; Litvan I; Filoteo JV; Geurtsen GJ; Weintraub D;
    Mov Disord; 2018 Nov; 33(11):1750-1759. PubMed ID: 30216541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
    Fernández-Blázquez MA; Ávila-Villanueva M; Maestú F; Medina M
    J Alzheimers Dis; 2016 Mar; 52(1):271-81. PubMed ID: 27060949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.
    Biundo R; Weis L; Pilleri M; Facchini S; Formento-Dojot P; Vallelunga A; Antonini A
    J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.
    Litvan I; Aarsland D; Adler CH; Goldman JG; Kulisevsky J; Mollenhauer B; Rodriguez-Oroz MC; Tröster AI; Weintraub D
    Mov Disord; 2011 Aug; 26(10):1814-24. PubMed ID: 21661055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis.
    Baiano C; Barone P; Trojano L; Santangelo G
    Mov Disord; 2020 Jan; 35(1):45-54. PubMed ID: 31743500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
    Domellöf ME; Ekman U; Forsgren L; Elgh E
    Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.